Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06).
The Oncologist
Lee, Su Jin SJ; Kim, Tae Min TM; Kim, Yu Jung YJ; Jang, Kee-Taek KT; Lee, Hyo Jin HJ; Lee, Soon Nam SN; Ahn, Mi Sun MS; Hwang, In Gyu IG; Lee, Suee S; Lee, Moon-Hee MH; Lee, Jeeyun J